bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16A noninvasive lung cancer test called CyPath Lung, developed by bioAffinity Technologies, will be showcased at the Cleveland Clinic's yearly symposium on lung cancer.
